Specialist Medical Review Council
Declarations
Section 196W
Veterans’ Entitlements Act 1986
Re: The decision by the Repatriation Medical Authority not to make
Statements of Principles for “chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine”.
Request for Review Declaration No. 34
- In relation to the decision of the Repatriation Medical Authority (RMA) not to make Statements of Principles for “chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine” the Council under s.196W(5)(b) of the VEA,
DECLARES that it was not satisfied on the balance of probabilities that “chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine” is a particular kind of injury or disease within the meaning of the VEA and accordingly that the sound medical-scientific evidence available to the RMA is insufficient to justify the making of Statements of Principles in respect of “chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine”.
| | |
Charles Guest Presiding Councillor | Yun Hwang Councillor | Nicole Jones Councillor |
| | |
Jonathan Phillips Councillor | Pauline Langeluddecke Councillor | |
The Common Seal of the ) Specialist Medical Review ) Council was affixed by ) authority of the Council in ) the presence of: ) | |
| |
|
|
Jan Bowman Registrar, SMRC Dated this 17th day of September 2018 |
|
|
|
Overview
The Veterans’ Entitlements Act 1986 was enacted by the Parliament of Australia to provide a legislative framework for the entitlement of veterans and their families to various forms of support and compensation. This Act was introduced to address the need for a comprehensive system that recognises and compensates for injuries and diseases sustained or contracted during military service. One of the key gaps it aimed to fill was the lack of a structured, evidence-based approach to determining which conditions are service-related and thus eligible for compensation. The Specialist Medical Review Council, acting under Section 196W of the Act, plays a crucial role in reviewing and making declarations regarding the medical evidence pertinent to these claims. In the context of chemically-acquired brain injury caused by mefloquine, tafenoquine, or primaquine, the Council was tasked with determining whether the available medical-scientific evidence was sufficient to justify the creation of Statements of Principles, which are integral to the assessment and approval of related compensation claims.
Scope and Application
The Specialist Medical Review Council Declarations Section 196W of the Veterans’ Entitlements Act 1986 applies to decisions made by the Repatriation Medical Authority regarding the recognition of particular kinds of injuries or diseases for the purposes of veterans' entitlements. This Act pertains specifically to the Council’s review and declaration concerning the RMA's decision not to establish Statements of Principles for "chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine". The Act is applicable within the Commonwealth jurisdiction and is concerned with the review of medical evidence and its sufficiency to warrant the recognition of such injuries. The Council’s declaration under this section reflects its determination that the available medical-scientific evidence was not sufficient to satisfy the required threshold for making Statements of Principles. There are no stated exclusions or exemptions within the scope of this specific declaration, but the application of the Act can be extended or restricted through subordinate instruments that may provide further detail on the processes and criteria for such reviews.
Key Provisions
The key operative sections of the Specialist Medical Review Council Declarations (Re: The decision by the Repatriation Medical Authority not to make Statements of Principles for “chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine”) are sections 196W and 196W(5)(b) of the Veterans’ Entitlements Act 1986 (VEA). Section 196W(5)(b) empowers the Specialist Medical Review Council to review decisions made by the Repatriation Medical Authority (RMA) concerning Statements of Principles, which are critical determinations for the eligibility of veterans for certain benefits. The Council's declaration under this section addresses the RMA's decision not to recognise chemically-acquired brain injury caused by specific medications (mefloquine, tafenoquine, or primaquine) as a particular kind of injury or disease under the VEA. The declaration states that the Council was not satisfied on the balance of probabilities that such injuries qualify as specific conditions under the Act, based on the medical-scientific evidence available to the RMA.
The obligations and requirements imposed by this Act on the parties involved primarily revolve around the process of reviewing and determining eligibility for veterans' benefits. The Specialist Medical Review Council must conduct a thorough review of the RMA's decisions, ensuring that such reviews are based on the available medical-scientific evidence. The Council must also communicate its findings clearly and authoritatively, as demonstrated in this declaration, which specifies the Council's reasoning and the evidence considered. The RMA, in turn, must provide all relevant information and evidence to the Council to facilitate this review process. These obligations ensure that decisions about veterans' entitlements are made with due consideration of the highest standards of medical evidence and rationale.
The consequences for non-compliance or breaches of the provisions outlined in the Act are significant, although the specific penalties for such breaches are not detailed within the text provided. Generally, breaches of the obligations under the VEA could lead to civil or criminal penalties, depending on the nature and severity of the breach. Civil penalties might include fines or compensation claims, while criminal penalties could result in imprisonment or substantial fines. The maximum penalties would depend on the specific provisions breached and the jurisdiction's sentencing guidelines. These potential consequences underscore the importance of adhering to the statutory obligations and the thorough review processes mandated by the Act.